Relationship of Retinal Vacular
Changes to BP
Classic Clinical Effects of Hypertension on the Eye
Hypertensive retinopathy refers to changes in the retina in response to elevated BP. Similar changes in the choroidal and optic nerve circulations are referred to as hypertensive choroidopathy and hypertensive optic neuropathy, respectively. 13 Of the 3, hypertensive retinopathy is by far the most common manifestation and appears earlier and at milder stages of hypertension than choroidopathy and optic neuropathy. 14 Hypertensive retinopathy is broadly divided into different stages, including vasoconstrictive, sclerotic, exudative, and malignant hypertension phases. 15, 16 These phases are not always sequential. For example, in patients with acutely raised BP, signs of retinopathy reflecting the exudative stage (eg, retinal hemorrhage) may be present without features of the sclerotic stage (eg, arteriovenous nicking). In fact, hypertensive retinopathy signs are detected frequently in persons without a known history of hypertension. 11 There have been many different classifications for hypertensive retinopathy. Traditionally, the Keith-Wagener-Baker system classifies patients with hypertension into 4 groups of increasing severity. 17 A simplified classification of hypertensive retinopathy based on prognosis of different signs from recent population-based data has been proposed (Table S1 in the online-only Data Supplement). 15 
Measurement of Retinal Vascular Caliber
To document generalized retinal arteriolar narrowing, one of the early signs of hypertensive retinopathy, computer software was designed to measure retinal vessel caliber in an objective manner. The most widely used program was first developed in the Atherosclerosis Risk in Communities (ARIC) Study 18 in which retinal vascular caliber was measured within a zone 0.5 to 1.0 disc diameter away from the optic disc margin. 19 Such methods can allow measurements of retinal vessel widths (caliber or diameter) to quantify generalized arteriolar narrowing objectively and reliably ( Figure S3A in the online-only Data Supplement) 20 and therefore improve the sensitivity and specificity in detecting retinal microcirculatory alterations. Table 1 shows the parameters for measurement of retinal vascular caliber from retinal photographs in clinical research.
Recent epidemiological studies using such methods have shown that changes in retinal vascular caliber are associated with a range of systemic factors. 20 The associations between retinal vascular caliber and BP (concurrent, past, and future), TOD, and CVD in general population-based studies are summarized (Table S2) . Such associations remain statistically significant even after multivariate adjustment for other cardiovascular factors. These studies provide strong evidence that retinal vascular caliber measurement can be used as a research tool to better understand the relationship between the retinal microvasculature and systemic diseases and also potentially used in clinical practice for retinal assessment.
Nevertheless, the measurement of retinal vascular caliber from photographs largely reflects the width of the red blood cell column (ie, internal lumen diameter), 21 and it does not capture vessel wall because the wall is transparent to light. The variation attributed to cardiac cycle is also a matter of concern. 22 Finally, specialized computer software and trained technicians are required for such measurements and, thus, not yet widely available for clinical use.
Relationship of Retinal Vascular Changes With Concurrent and Past BP
Retinal Vascular Changes and Concurrent BP Retinal vascular changes, in particular, retinal arteriolar narrowing, are strongly correlated with concurrent elevated BP levels. 13, 20 The ARIC Study initially demonstrated the association between generalized arteriolar narrowing, as measured by the computer-assisted method, and concurrent elevated BP. 23 Such relationship was confirmed in different study populations subsequently. It is noted that the strength of the cross-sectional association between retinal arteriolar narrowing and BP varies with age 24 but is similar in different racial or ethnic groups. 25, 26 Retinal venular diameter, not traditionally considered part of the spectrum of hypertensive retinopathy signs, may convey additional information regarding the state of the retinal vasculature and systemic health. New studies found that retinal venular widening or dilatation is also related to concurrent elevated BP levels, 24, 27, 28 suggesting that venules may exhibit different optimal flow characteristics across the vascular network compared with arterioles in the presence of hypertension. 29 This may also suggest that venules are not merely passive conductance vessels but represent a dynamic component responsive to changes in the microcirculation. 5 Nevertheless, the pathophysiological mechanisms underlying with retinal vascular changes at baseline were more likely to develop an incident clinical stroke. 35 The ARIC Study further demonstrated that persons who had both cerebral magnetic resonance imaging lesions and retinopathy signs were at substantially higher risk of incident clinical stroke than those without either abnormality. 36 Subsequent studies consistently reported that persons with retinal vascular changes at baseline were more likely to develop stroke, 27,37-40 even after controlling for traditional risk factors. Importantly, a recent metaanalysis confirmed that wider retinal venular caliber, rather than narrower arteriolar caliber, is related to risk of stroke, which provides evidence that venules may play a key role in pathogenesis of microvascular stroke. 41 Some recent studies further demonstrated that retinal vascular changes may allow further refinement and subtyping of stroke. In a multicenter study of patients with acute stroke, different hypertensive retinopathy signs were associated with specific stroke subtypes. 42 For example, retinal arteriolar narrowing was associated with lacunar stroke, whereas retinal hemorrhages were linked with cerebral hemorrhages. 39, [42] [43] [44] [45] These findings suggest that retinal vascular changes reflect specific cerebral microvasculopathy and may further help to understand the underlying pathologic mechanisms.
Relationship With Subclinical Stroke
In addition, it is increasingly evident that retinal vascular changes are associated with subclinical cerebral changes. For example, in the ARIC Study, middle-aged, generally healthy, persons with retinal vascular changes were more likely to have subclinical magnetic resonance imaging-defined cerebral infarction and cerebral white matter lesions than those without these signs. 36, 46 Recent prospective data from the ARIC Study further showed that retinal vascular changes are associated with incident cerebral atrophy, incident cerebral infarct, incident lacunar infarct, and white matter lesion incidence and progression, independent of traditional risk factors. 47, 48 These data provide strong evidence that retinal vascular Retinal arteriolar branching asymmetry ratio Increased Current blood pressure 28 Retinal arteriolar length:diameter ratio Increased Current blood pressure, 121 essential and malignant phase hypertension, 122 and stroke mortality 88 Retinal arteriolar branching coefficient (optimality ratio)
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Ischemic heart disease mortality 88 Retinal arteriolar optimality parameter (deviation of junction exponent) Decreased Peripheral vascular disease changes mirror preclinical structural changes in the cerebral microcirculation and support the hypothesis that retinal microvascular changes provide insights into the microvascular structure and function in the cerebral microcirculation.
Coronary Artery Disease and Heart Failure
There is also evidence that retinal vascular changes are predictive of clinical coronary artery disease events; however, the results of these studies show less consistent associations than with stroke. 27, [49] [50] [51] A meta-analysis of 6 population-based studies provides robust evidence to confirm that retinal vascular caliber is associated with an increased risk of coronary artery disease in women but not in men. 52 Furthermore, in the ARIC Study, persons with retinopathy were 3 times more likely to develop congestive heart failure than those without retinopathy, whereas controlling for the presence of other cardiovascular risk factors. 53 Nevertheless, the incremental predictive ability over that of the Framingham model was only modest and unlikely to translate meaningfully into clinical practice.
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Renal Disease
Animal studies showed pathological changes in the retinal and renal microcirculation are correlated in spontaneously hypertensive rats. 55 The significance of hypertensive retinopathy signs as risk indicators has long been recognized in humans with renal disease. 12 Retinal vascular changes assessed by standardized photographic methods were demonstrated to be associated with microalbuminuria and renal impairment in cross-sectional studies. [56] [57] [58] Such association was independent of BP, diabetes mellitus, and other risk factors and was also seen in persons without diabetes mellitus or hypertension. However, the findings from prospective studies are mixed. Retinal arteriolar narrowing was associated with chronic kidney disease among whites in the Multi-Ethnic Study of Atherosclerosis 59 and with 6-year change in serum creatinine among the ARIC population, 60 whereas no association was found among elderly adults in the Cardiovascular Health Study 61 and elderly whites in the Beaver Dam Eye Study.
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CVD Mortality
Retinal vascular changes have also been shown to correlate with increased risk of CVD mortality, stroke mortality, and coronary heart disease mortality. For example, in the Blue Mountains Eye Study, persons with retinopathy signs were more likely to die from coronary heart disease than persons without this sign, with an equivalent risk similar to that of diabetes mellitus. 63 Also, in the Ibaraki Prefectural Health Study with 87 890 individuals, both hypertensive and nonhypertensive subjects with mild retinopathy signs were more likely to die from CVD mortality, independent of traditional cardiovascular risk factors. 64 These data suggest that retinal vascular changes may convey additional prognostic information than other risk measures of CVD.
Pathogenesis of Cardiovascular Events
There is emerging evidence of a significant role of the microcirculation on CVD and TOD. Studies show that alterations in structure and function of small arteries may contribute to CVD and TOD in hypertensive patients. For example, an increased media:lumen ratio of gluteal subcutaneous small arteries (abnormal resistance artery structure) can predict cardiovascular events in essential hypertension. Changes in retinal vasculature (caliber, tortuosity, fractals, bifurcation, and wall:lumen ratio) may reflect similar changes in the systemic peripheral circulation (eg, vasoconstriction, intimal thickening, and medial hyperplasia), providing insights into the structure and function of small vessels that are important in hypertension and associated TOD and CVD. Recent studies also showed that reduced large artery compliance is associated with narrowed retinal arterioles, independent of age, BP levels, and other cardiovascular risk factors. These studies further support the concept that diminished large-artery compliance is associated with microvascular dysfunction, and thus both small and large (ie, resistive versus compliance) arteries are important in the pathogenesis of CVD and TOD.
Retinal Vascular Changes as a Model to Study Early Correlates of Hypertension Role of Microcirculation in the Pathogenesis of Hypertension
The microcirculation plays a critical role in the pathophysiology of hypertension. Animal models, in vitro experiments, and clinical studies have demonstrated that microcirculatory changes (eg, arteriolar narrowing and capillary rarefaction) are linked with the development of hypertension. 1, 8 It is suggested that alternations in the structure and function of the microcirculation are one of the earliest changes in the pathogenesis of hypertension, including impaired vasomotor tone leading to enhanced vasoconstriction or reduced vasodilator responses, anatomic alterations to the structure of individual precapillary resistance vessels, and rarefaction of arterioles or capillaries within a given vascular bed. 6 Investigating the microvascular structure and function in retina may therefore improve the understanding of the pathogenesis of hypertension and related TOD and CVD. The Figure illustrates the contribution of studying retinal vascular changes to the understanding of the pathogenesis of hypertension and related TOD and cardiovascular events.
Retinal Vascular Changes and Future Risk of Hypertension
Retinal Vascular Changes and Risk of Hypertension
Although there were studies that showed that arteriolar narrowing has been found to precede the development of hypertension in rats,peripheral vasoconstriction, may be an early preclinical marker of hypertension.
Retinal Vascular Changes and BP in Children
Importantly, new studies in children have demonstrated that the association between retinal arteriolar narrowing and elevated BP can be observed even in children as young as 4 to 5 years of age. These findings suggest that the impact of elevated BP on the retinal microcirculation occurs in early life, 71, 72 which may then track through to adulthood, even before the onset of overt hypertension. Furthermore, the association of parental history of hypertension with narrower retinal arteriolar caliber in young girls aged 6 years 73 indicates the need for instituting CVD prevention measures early in life among offspring of hypertensive parents.
Retinal Vascular Changes and Hypertension Genes
In addition, recent genetic epidemiology studies have provided clues to new vascular pathophysiological processes linked to changes in retinal vascular caliber. A genome-wide linkage analysis from the Beaver Dam Eye Study demonstrated that retinal arteriolar caliber links to multiple genetic loci, which are associated with regulation of BP, endothelial function, and vasculogenesis, 74 suggesting that retinal arteriolar narrowing may be a surrogate marker of an individual's genetic predisposition to hypertension. 75 These findings may allow understanding of the contribution and biological mechanisms of microcirculatory changes that underlie hypertension.
Advances in the Retinal Vascular Imaging Technologies Assessment of Global Geometrical and Branching Parameters of the Retinal Vasculature
Previous studies have focused on retinal vascular caliber for quantifying the retinal vascular changes using computerassisted methods. The human circulatory system is a branching system that conforms to optimum design principal (Murray principle of minimum work). 76 Deviations or alterations from optimal architecture are speculated to result in impaired microcirculatory transport, reduced efficiency, and, thereby, a greater risk of vascular damage. [76] [77] [78] With innovative technology in retinal photography and computing image processing techniques, new computer-based programs were developed ( Figure S3B ) to perform objective and quantitative assessment of novel classes of retinal geometrical and branching parameters, such as tortuosity, fractal dimension, branching angles, and vascular length:diameter ratio reliably and rapidly ( Figure S3C through S3E in the online-only Data Supplement). Examining the branching pattern of the retinal vasculature may indicate the optimal state of the retinal microcirculation and provide additional cardiovascular risk information to enable better predictive ability of cardiovascular outcomes.
Recent clinical studies showed that these new parameters are related to microvascular damage, such as hypertension, 28, [79] [80] [81] [82] [83] stroke, [84] [85] [86] CVD mortality, 87,88 kidney dysfunction, 89, 90 and diabetic retinopathy, [90] [91] [92] suggesting that vascular disease can be detected and monitored by measuring subtle damage from the retinal branching vasculature. Yet, it remains unproven as to whether the deviations cause or correlate with diseases. Table 2 summarizes the associations between the new retinal vascular measures and BP, TOD, and CVD from the clinical studies. In addition to retinal vascular caliber, changes in these new parameters may reflect similar changes in the systemic peripheral, on the level of BP and occurrence of hypertension, and on CVD.
Assessment of Dynamic Retinal Vascular Changes
Endothelial dysfunction, characterized by reduced nitric oxide bioavailability, plays a central role in the pathogenesis of vascular diseases, including hypertension. In the retina, nitric oxide seems to play a role in flicker-induced vasodilation of the human retinal vasculature. 93 The normal physiological response to stimulation with diffuse luminance flicker is dilatation of retinal vessels mediated by nitric oxide, and this physiological response becomes altered in a variety of pathological states. The dynamic vessel analyzer is a commercially developed system to provide a dynamic analysis of retinal vascular dilatation in response to diffuse illuminance flicker, which is a noninvasive measurement of vascular reactivity in the retinal microcirculation. Recent small sample size studies demonstrated a reduced flicker response in retinal arteriole dilation in hypertension. 94, 95 These studies suggest that the flicker response of retinal vessel diameter could be a new and noninvasive method for detecting early functional damage (endothelial dysfunction) and may potentially indicate the improved microvascular function under antihypertensive therapy.
Assessment of Retinal Vascular Flow
Vascular remodeling of small and large vessels is a characteristic feature in hypertension, resulting in an increase in the media:lumen ratio or wall:lumen ratio of small arteries and arterioles by increasing vascular resistance. Scanning laser Doppler flowmetry with automatic full-field perfusion imaging analysis is another novel approach to enable noninvasive and easily repeatable assessment of retinal arteriolar structure. Such assessment allows quantification of the outer and lumen diameters of the retinal vessels and calculation of wall thickness, wall:lumen ratio, and retinal capillary flow by assessing retinal vessels widths in a dynamic fashion to analyze vascular remodeling of retinal arterioles in vivo ( Figure S4) . 96, 97 The test-retest measurements of retinal arteriolar structure using scanning laser Doppler flowmetry has been shown to be reliable. 98 The validity of the wall:lumen ratio of retinal arterioles has also been assessed by examining the correlation of media:lumen ratio of subcutaneous small arteries with micromyography, providing evidence that retinal arterioles undergo remodeling similar to that seen in arterioles of the subcutaneous tissue. 99 Using such approach, an increased wall:lumen ratio of retinal arterioles was initially demonstrated in treated hypertensive patients with cerebrovascular event, 100 as well as in untreated hypertensive patients. 101 Further recent studies report that increased wall:lumen ratio of retinal arterioles is correlated with increased BP, urinary albumin excretion, and cerebrovascular damage. [100] [101] [102] [103] Compared with assessment of retinal arteriolar narrowing with retinal fundus photography, assessing wall:lumen ratio of retinal arterioles may provide further indication on vascular remodeling, but its prognostic significance has not yet been evaluated in prospective studies, and the technical availability of scanning laser Doppler flowmetry is limited.
Other New Imaging Tools for Retinal Analysis
Advanced retinal imaging tools, for example, ultra-widefield retinal imaging, adaptive optics, retinal oximeter, and Doppler optical coherence tomography, have been launched recently to further measure and analyze the structure and function of the retina, including peripheral retinal vasculature, foveal capillary network, retinal oxygen saturation, retinal blood flow, and choroidal vasculature. These new retinal imaging tools are promising to examine the link between eye and hypertension in advance. The prognostic significance of using these new technologies is yet to be evaluated particularly in longitudinal study.
Unresolved Questions and Future Directions Is a Clinical Retinal Examination Useful for Assessment of Hypertensive Retinopathy?
The clinical assessment of hypertensive retinopathy signs with the use of an ophthalmoscope has long been regarded as part of the standard evaluation of patients with arterial hypertension. 15 Nevertheless, high variability of direct fundoscopic examination between observers has been shown, and it has been argued that a routine clinical assessment of qualitative hypertensive retinopathy signs is of limited additional value in the management of patients with hypertension. 104 Moreover, the evidence of a prognostic impact of early retinal vascular abnormalities on cardiovascular risk stratification is less well established. 105 However, most international hypertension management guidelines, including the US Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, the British Society of Hypertension, the European Society of Hypertension, and the European Society of Cardiology, [106] [107] [108] still emphasize that hypertensive retinopathy, with left ventricular hypertrophy and renal impairment, is an indicator of TOD, and its presence should be an indication for a more aggressive approach in managing these hypertensive patients. 107 Digital retinal fundus photography is a potentially sensitive and precise method for assessing retinal vascular changes. Studies showed that the reliability of retinal vascular changes via standardized assessment using digital retinal photography is high. 20 Moreover, new approaches using computer-assisted programs to quantify retinal vascular changes offer increasingly accurate and repeatable assessment of the retinal vasculature. 28 Development of standardized photographic methods for the assessment of retinal vascular changes may therefore enable more accurate stratification for cardiovascular risk in patients with hypertension for better management.
Can Retinal Vascular Imaging Be a Surrogate Measure to Evaluate New Therapeutic Interventions in Hypertension?
Treatment of hypertension is associated with important reductions in risk of major vascular events including stroke and coronary heart disease. Retinal analysis allows the study of the microcirculation in human hypertension not only with respect to pathophysiological questions but also in relation to new therapies for hypertension. Studies have demonstrated regression of hypertensive retinopathy signs in response to BP reduction and that regression is different in response to different antihypertensive regimens (eg, angiotensin-converting enzyme inhibitors seem to have a more favorable effect on the retinal vasculature). [109] [110] [111] Changes in retinal vasculature, markers of hypertensive state, may act as therapeutic targets capable of reflecting the effectiveness of antihypertensive drug treatment in controlling elevated BP values. Nevertheless, data describing the impact of antihypertensive therapy on retinal vascular changes are still lacking. There needs to be more studies to demonstrate regression of retinal vascular changes via interventions. The potential impact of antihypertensive drug treatment on the patterns of the retinal microcirculation remains unclear. Further prospective controlled trials are required to clarify whether specific reduction of retinal vascular damage also reduces the morbidity and mortality associated with CVD. Moreover, targeting retinal microcirculation to prevent endorgan damage beyond BP reduction is another possible therapeutic strategy in the treatment of hypertension.
Is Retinal Vascular Imaging Useful as a Tool to Screen for CVD?
A substantial proportion of CVD is not explained by traditional risk factors alone. Current cardiovascular biomarkers (eg, C-reactive protein) and risk assessment methods (eg, Framingham risk score model) can provide only modest improvements in predictive accuracy. 112, 113 Despite consistent large epidemiological studies demonstrating the relationship between retinal vascular changes and risk of CVD (as reviewed above), retinal vascular imaging is only used as a research tool
and not yet as a clinical tool of daily routine. There remains scepticism whether retinal vascular assessment can provide additional prognostic information on cardiovascular risk prediction, in addition to traditional risk factors. Furthermore, no studies have compared the assessment of various organ damage parameters in their ability to provide additional predictive power of cardiovascular complications. Therefore, testing and validating the clinical use of retinal vascular imaging for cardiovascular risk prediction and risk stratification, particularly in asymptomatic people, are warranted to further clarify.
What Are Technological Challenges in Retinal Vascular Imaging?
Although standardized photographic protocols are available for the assessment of retinal vascular changes, there are still different technological challenges in retinal vascular imaging that may lead to misclassification or less precision of the measurement. First, refractive error and axial length may affect the magnification and apparent dimensions of retinal structures on fundus photography. 114 Other ocular factors, including retinal pigmentation, pupil dilation, presence of cataract, and other ocular media opacities, may vary image brightness, focus, and contrast, which significantly affect the measurement of retinal vascular changes. [115] [116] [117] Furthermore, photographic technique and camera type may also affect the image quality for retinal fundus photography. Such possible ocular factors and confounders should be controlled for (eg, factoring in magnification effect and iris color) in the further development of retinal vascular imaging technology.
Currently, retinal vascular changes are either manually or semiautomatically assessed in reading centers. Observer's manual input is still required, which may introduce additional variability in measurements. Further technical refinement should be performed to minimize variability in measurements. Full automation in the measurement process and abnormalities detection is still underdeveloped and not yet ready for end user.
Conclusions
The retinal vasculature is a unique biological model to study both the manifestations and origins of hypertension. Advanced retinal vascular imaging technologies have been developed to allow a more objective and precise assessment of retinal vascular changes. Further development of retinal vascular analyses and standardized measurement protocols, evaluation of the clinical use of retinal vascular imaging in assessing cardiovascular risk prediction, and using retinal vascular imaging to test antihypertensive treatments will allow the translation of retinal vascular imaging as a tool to improve the diagnosis, prognosis, and management of hypertension in clinical practice.
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